Reen Medical Group Inc - Medicare Primary Care in Ridgecrest, CA

Reen Medical Group Inc is a medicare enrolled primary clinic (Internal Medicine) in Ridgecrest, California. The current practice location for Reen Medical Group Inc is 1525 N Norma St Ste B, Ridgecrest, California. For appointments, you can reach them via phone at (760) 463-1613. The mailing address for Reen Medical Group Inc is 1525 N Norma St Ste B, Ridgecrest, California and phone number is (760) 463-1613.

Reen Medical Group Inc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1679828776. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (760) 463-1613.

Contact Information

Reen Medical Group Inc
1525 N Norma St Ste B
Ridgecrest
CA 93555-6536
(760) 463-1613
(760) 463-1614

Primary Care Clinic Profile

Full NameReen Medical Group Inc
SpecialityInternal Medicine
Location1525 N Norma St Ste B, Ridgecrest, California
Authorized Official Name and PositionAmikjit S Reen (CEO/PHYSICIAN)
Authorized Official Contact5105520967
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Reen Medical Group Inc
1525 N Norma St Ste B
Ridgecrest
CA 93555-6536

Ph: (760) 463-1613
Reen Medical Group Inc
1525 N Norma St Ste B
Ridgecrest
CA 93555-6536

Ph: (760) 463-1613

NPI Details:

NPI Number1679828776
Provider Enumeration Date07/16/2012
Last Update Date08/26/2014

Medicare PECOS Information:

Medicare PECOS PAC ID3971753005
Medicare Enrollment IDO20121025000216

News Archive

Merck's SAFLUTAN launched in the UK and Spain

Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension.

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Curvy women have the edge on their skinny sisters

According to American researchers curvaceous women may have the edge on their skinny sisters in more ways than one.

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors - one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Reen Medical Group Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1679828776NPI-NPPES
CL440AOtherPTAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Secondary
207R00000XInternal Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Reen Medical Group Inc acts as a billing entity for following providers:
Provider NameAmikjit Singh Reen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1720061112
PECOS PAC ID: 3870521925
Enrollment ID: I20050729000620

News Archive

Merck's SAFLUTAN launched in the UK and Spain

Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension.

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Curvy women have the edge on their skinny sisters

According to American researchers curvaceous women may have the edge on their skinny sisters in more ways than one.

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors - one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

Read more Medical News

› Verified 1 days ago

Provider NameSandeep Reen
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1912284621
PECOS PAC ID: 2466615463
Enrollment ID: I20120717000235

News Archive

Merck's SAFLUTAN launched in the UK and Spain

Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension.

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Curvy women have the edge on their skinny sisters

According to American researchers curvaceous women may have the edge on their skinny sisters in more ways than one.

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors - one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

Read more Medical News

› Verified 1 days ago

Provider NameSavita A Dongre
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134875123
PECOS PAC ID: 3577946177
Enrollment ID: I20220815001826

News Archive

Merck's SAFLUTAN launched in the UK and Spain

Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension.

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Curvy women have the edge on their skinny sisters

According to American researchers curvaceous women may have the edge on their skinny sisters in more ways than one.

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors - one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

Read more Medical News

› Verified 1 days ago

News Archive

Merck's SAFLUTAN launched in the UK and Spain

Merck & Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today. SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension.

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Curvy women have the edge on their skinny sisters

According to American researchers curvaceous women may have the edge on their skinny sisters in more ways than one.

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors - one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

Read more News

› Verified 1 days ago


Internal Medicine in Ridgecrest, CA

Furnace Branch Urgent Care Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 900 N Heritage Dr Ste A, Ridgecrest, CA 93555
Phone: 760-446-4571    Fax: 760-446-3819
Kain Kumar Md Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 829 N Downs St, Suite B, Ridgecrest, CA 93555
Phone: 760-371-7600    Fax: 760-371-2200
Sivalingam Medical Corporation, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1535 N China Lake Blvd Ste A, Ridgecrest, CA 93555
Phone: 760-446-1691    Fax: 760-446-1642
Owens Peak Medical Clinic Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1131 N China Lake Blvd, Ridgecrest, CA 93555
Phone: 760-375-0100    Fax: 760-375-0110
Desert Oasis Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1041 N China Lake Blvd Ste A, Ridgecrest, CA 93555
Phone: 760-446-2984    Fax: 760-446-2987
Heather Stone Medical Clinic
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 900 N Heritage Dr, Bldg E, Ridgecrest, CA 93555
Phone: 760-446-4571    
Rrh Mobile Health Clinic
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1111 N China Lake Blvd, Ridgecrest, CA 93555
Phone: 760-499-3855    Fax: 760-499-3870

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.